368 related articles for article (PubMed ID: 26025053)
21. Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.
Pevzner A; Schoser B; Peters K; Cosma NC; Karakatsani A; Schalke B; Melms A; Kröger S
J Neurol; 2012 Mar; 259(3):427-35. PubMed ID: 21814823
[TBL] [Abstract][Full Text] [Related]
22. [Autoantibodies in myasthenia gravis].
Motomura M; Narita Masuda T
Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
[TBL] [Abstract][Full Text] [Related]
23. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
[TBL] [Abstract][Full Text] [Related]
24. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
25. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
Ohta R; Motomura M
Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
[TBL] [Abstract][Full Text] [Related]
26. [Seronegative myasthenia gravis].
Gajdos P
Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
[TBL] [Abstract][Full Text] [Related]
27. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Saka E; Topcuoglu MA; Akkaya B; Galati A; Onal MZ; Vincent A
Neurology; 2005 Sep; 65(5):782-3; author reply 782-3. PubMed ID: 16157930
[No Abstract] [Full Text] [Related]
28. Myasthenia gravis patients with anti-MuSK antibodies.
Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
[TBL] [Abstract][Full Text] [Related]
29. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
[TBL] [Abstract][Full Text] [Related]
31. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
[TBL] [Abstract][Full Text] [Related]
32. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
Berrih-Aknin S; Le Panse R
Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
[TBL] [Abstract][Full Text] [Related]
33. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
[TBL] [Abstract][Full Text] [Related]
34. Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy.
Skriapa L; Zisimopoulou P; Trakas N; Grapsa E; Tzartos SJ
J Neuroimmunol; 2014 Nov; 276(1-2):150-8. PubMed ID: 25262156
[TBL] [Abstract][Full Text] [Related]
35. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
36. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
37. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
Guptill JT; Sanders DB; Evoli A
Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
[TBL] [Abstract][Full Text] [Related]
38. [Seronegative myasthenia gravis].
Catar O; Aubé-Nathier AC; Nadaj-Pakleza A
Med Sci (Paris); 2017 Nov; 33 Hors série n°1():34-38. PubMed ID: 29139384
[No Abstract] [Full Text] [Related]
39. The features of myasthenia gravis with autoantibodies to MuSK.
Lavrnic D; Losen M; Vujic A; De Baets M; Hajdukovic LJ; Stojanovic V; Trikic R; Djukic P; Apostolski S
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1099-102. PubMed ID: 16024887
[TBL] [Abstract][Full Text] [Related]
40. [Anti-muscle-specific tyrosine kinase (MuSK) antibody].
Ohta M; Ohta K; Shigemoto K; Shimoda Y
Nihon Rinsho; 2010 Jun; 68 Suppl 6():633-6. PubMed ID: 20942150
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
